Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas-Reference-Cited by-同舟云学术

Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas

Published:2014-04-22 Issue:9 Volume:61 Page:1598-1602
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Widemann Brigitte C.¹,Babovic-Vuksanovic Dusica²,Dombi Eva¹,Wolters Pamela L.¹,Goldman Stewart³,Martin Staci¹,Goodwin Anne¹,Goodspeed Wendy¹,Kieran Mark W.⁴,Cohen Bruce⁵,Blaney Susan M.⁶,King Allison⁷,Solomon Jeffrey⁸,Patronas Nicholas⁹,Balis Frank M.¹¹⁰,Fox Elizabeth¹¹⁰,Steinberg Seth M.¹¹,Packer Roger J¹²

Affiliation:

1. Pediatric Oncology Branch; National Cancer Institute; Bethesda Maryland

2. Department of Medical Genetics; Mayo College of Medicine; Rochester Minnesota

3. Ann and Robert H Lurie Children's Hospital of Chicago; Chicago Illinois

4. Dana-Farber/Children's Hospital Cancer Center; Boston Massachusetts

5. Cleveland Clinic; Cleveland Ohio

6. Texas Children's Hospital; Houston Texas

7. St. Louis Children's Hospital; St. Louis Missouri

8. Expert Image Analysis LLC; Potomac Maryland

9. Diagnostic Radiology Department, Clinical Center; National Institutes of Health; Bethesda Maryland

10. The Children's Hospital of Philadelphia; Philadelphia Pennsylvania

11. Biostatistics and Data Management Section; National Cancer Institute; Bethesda Maryland